18 August 2025 in Journal of Biological Chemistry
Metabolism and post-translational modifications (PTMs) are intrinsically linked and the number of identified metabolites that can covalently modify proteins continues to increase. This metabolism/PTM crosstalk is especially true for lactate, the product of anaerobic metabolism following glycolysis. Lactate forms an amide bond with the ε-amino group of lysine, a modification known as lysine lactylation, or Kla. Multiple independent mechanisms have been proposed in the formation of Kla, including p300/CBP-dependent transfer from lactyl-CoA, a reactive intermediate lactoylglutathione species that non-enzymatically lactylates proteins, and several enzymes are reported to have lactyl transferase capability. We recently discovered that class I histone deacetylases (HDACs) 1, 2, and 3 can all reverse their canonical chemical reaction to catalyze lysine β-hydroxybutyrylation. Here we tested the hypothesis that HDACs can also catalyze Kla formation. Using biochemical, pharmacological, and genetic approaches, we found that HDACs are sufficient to catalyze Kla formation and that HDACs are a major driver of lysine lactylation. Dialysis experiments confirm this is a reversible reaction that depends on lactate concentration. We also directly quantified intracellular lactyl-CoA and found that Kla abundance can be uncoupled from lactyl-CoA levels. Therefore, we propose a model in which the majority of Kla is formed through enzymatic addition of lactate by HDACs 1, 2, and 3.
19 November 2026 in Cellular and Molecular Neurobiology
Cerebrospinal fluid (CSF) secretion by the choroid plexus depends on coordinated ion transport across the blood-CSF barrier (BCSFB). Among basolateral transporters, the Na + -dependent Cl − /HCO 3 − exchanger NCBE (SLC4A10) has emerged as the major transporter responsible for sustaining the intracellular Na + and HCO 3 − required for CSF production. However, its role in choroid plexus transport physiology and its therapeutic potential have not been comprehensively synthesized. A systematic literature review was conducted across MEDLINE, Embase and Web of Science databases. Original peer-reviewed studies evaluating NCBE in the choroid plexus and relevant outcomes in ion transport, CSF dynamics, ventricular volume, or therapeutic modulation were included. Twenty-two studies met inclusion criteria. Across in vitro, in vivo and genetic studies, NCBE consistently localized to the basolateral membrane of choroid plexus epithelial cells and was a major mediator of Na + -dependent HCO 3 − transport. Genetic deletion of SLC4A10 in rodents markedly reduced ventricular volume, impaired intracellular pH recovery, and induced compensatory remodeling of choroid plexus transporter distribution. Human biallelic loss-of-function variants were associated with slit ventricles and neurodevelopmental abnormalities, paralleling in vivo findings. Further studies implicate NCBE regulation in multiple pathologic states including metabolic acidosis and posthemorrhagic hydrocephalus. However, mechanistic investigation has been limited by reliance on non-selective inhibitors which exhibit off-target effects and toxicity. Given its basolateral localization at the BCSFB, predominant enrichment within the CNS, and important role in choroid plexus ion transport, NCBE represents a promising molecular target for pharmacologic modulation of CSF secretion. However, the effect of selective pharmacologic NCBE inhibition on CSF secretion remains to be directly established. Development of selective NCBE inhibitors will enable more precise characterization of NCBE function and may ultimately enable new therapeutic strategies for hydrocephalus and other disorders of CSF dynamics. Graphical Abstract Effect of NCBE (SLC4A10) Knockout on Ventricular Morphology and Cerebrospinal Fluid Transporter Expression. Schematic contrasting wild-type choroid plexus transport (left) against the compensatory remodeling and ventricular morphology changes resulting from NCBE knockout (right). Loss of basolateral NCBE disrupts intracellular pH regulation, blunts apical microvilli, triggers compensatory apical-to-basolateral translocation of NHE1, and downregulates apical secretory machinery expression including Aquaporin 1 (AQP1) and Na + /K + ATPase (NKA).
12 November 2026 in Neurosurgery
BACKGROUND AND OBJECTIVES: Ventricular shunt tap is used in the evaluation of suspected shunt malfunction and infection, yet concerns regarding diagnostic reliability and infectious complications persist. We evaluated the diagnostic accuracy and safety of shunt tap for identifying proximal and distal shunt obstruction. METHODS: A retrospective study was performed including all patients undergoing ventricular shunt tap at a single institution. Inclusion criteria were (1) documented procedure note evaluating both proximal and distal function and (2) minimum 30-day follow-up. Operative findings during shunt revision served as the reference standard when surgery was performed. Patients managed nonoperatively without deterioration or shunt revision within 30 days were classified as not having mechanical obstruction. RESULTS: A total of 213 shunt taps across 94 patients met inclusion criteria. The median age was 30.2 years, and 50 patients (53.2%) were male. The median number of taps per patient was 1.5 (IQR 1-3; maximum 10). For proximal obstruction, shunt tap demonstrated 83.7% sensitivity and 98.8% specificity, with a positive predictive value of 94.7%, negative predictive value of 96.0%, positive likelihood ratio of 71.16, and negative likelihood ratio of 0.16. For distal obstruction, the sensitivity was 77.8% and specificity was 100%, with a positive predictive value of 100%, negative predictive value of 96.9%, positive likelihood ratio infinite, and negative likelihood ratio of 0.22. Opening pressure predicted proximal obstruction (area under the curve 0.839), with an optimal threshold ≤0.5 cmH 2 O yielding 87.0% sensitivity and 76.9% specificity. Distal runoff predicted distal obstruction (area under the curve 0.924), with an optimal threshold of ≤9.5 cmH 2 O yielding 100% sensitivity and 88.9% specificity. No shunt tap-related complications, shunt damage, or subsequent infections attributable to the procedure were identified. CONCLUSION: Ventricular shunt tap is safe and highly informative in evaluating suspected shunt malfunction. Abnormal proximal or distal flow demonstrated excellent specificity, increasing the post-test probability of true mechanical obstruction, while normal flow substantially reduced the likelihood of obstruction. These findings support shunt tap to guide diagnostic and operative decision-making in patients with suspected shunt malfunction.